(Q24200929)

inferred from title

cryptococcal meningitis

1 reference

Lawrence Mbuagbaw

6

0 references

Eugene J Kongnyuy

2

object named as

Eugene J Kongnyuy

0 references

author name string

Basile Njei

1

0 references

Sushil Kumar

3

0 references

Mbah P Okwen

4

0 references

Mari Jeeva Sankar

Cochrane Database of Systematic Reviews

5

0 references

publication date

28 February 2013

0 references

published in

0 references

cites work

Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Should antiretroviral therapy be delayed for 10 weeks for patients treated with fluconazole for cryptococcal meningitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Treatment of cryptococcosis in the setting of HIV coinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Optimum time to start antiretroviral therapy during HIV-associated opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

The changing face of AIDS-related opportunism: cryptococcosis in the highly active antiretroviral therapy (HAART) era. Case reports and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Safety, Censoring, and Intent‐to‐Treat Analysis: Dangers to Generalizability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

HIV-associated cryptococcal meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Managing cryptococcosis in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Optimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Treatment of acute cryptococcal meningitis in HIV-infected adults in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

7 January 2021

The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

7 January 2021

A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

7 January 2021

Concerns Regarding a Randomized Study of the Timing of Antiretroviral Therapy in Zimbabweans with AIDS and Acute Cryptococcal Meningitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

7 January 2021

Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-fungal treatment for acute cryptococcal meningitis in children with HIV?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

7 January 2021

Guidelines for the diagnosis and management of neurological complications of HIV infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009012.PUB2

7 January 2021